Finance
Finance
MwanzoBSX • NYSE
Boston Scientific Corp
$ 106.47
Kabla ya soko:
$ 106.52
(0.047%)+0.050
Imefungwa: 30 Jul, 06:25:45 GMT -4 · USD · NYSE · Kanusho
HisaHisa zinazouzwa MarekaniMakao yake makuu ni Marekani
Bei iliyotangulia
$ 105.84
Bei za siku
$ 106.10 - $ 107.25
Bei za mwaka
$ 71.88 - $ 108.94
Thamani ya kampuni katika soko
157.52B USD
Wastani wa hisa zilizouzwa
7.89M
Uwiano wa bei na mapato
63.39
Mgao wa faida
-
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD)Jun 2025Mabadiliko Tangu Mwaka Uliopita
Mapato
5.06B22.84%
Matumizi ya uendeshaji wa biashara
2.47B20.81%
Mapato halisi
797.00M145.99%
Kiwango cha faida halisi
15.75100.38%
Mapato kwa kila hisa
0.7520.97%
EBITDA
1.35B21.71%
Asilimia ya kodi ya mapato
15.52%
Jumla ya mali
Jumla ya dhima
(USD)Jun 2025Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
725.00M-75.11%
Jumla ya mali
Jumla ya dhima
Jumla ya hisa
22.44B
hisa zilizosalia
1.48B
Uwiano wa bei na thamani
7.05
Faida inayotokana na mali
Faida inayotokana mtaji
7.51%
Mabadiliko halisi ya pesa taslimu
(USD)Jun 2025Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
797.00M145.99%
Pesa kutokana na shughuli
Pesa kutokana na uwekezaji
Pesa kutokana na ufadhili
Mabadiliko halisi ya pesa taslimu
Mtiririko huru wa pesa
Kuhusu
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts and incorporated in Delaware, is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator which they call the EMBLEM subcutaneous implantable defibrillator. Over the last 20 years, Boston Scientific has been involved in a number of high-profile patent infringement cases and made extensive payouts, including 1.725 billion dollars to Johnson & Johnson, 85 million dollars to Nevro and 42 million dollars to TissueGen. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
29 Jun 1979
Wafanyakazi
53,000
Gundua zaidi
Huenda unavutiwa na
Orodha hii imetokana na maudhui uliyotafuta hivi majuzi, hisa unazofuatilia na shughuli zingine. Pata maelezo zaidi

Data na maelezo yote hutolewa “kama yalivyo” kwa madhumuni ya taarifa binafsi tu, wala hayanuii kuwa ushauri wa kifedha na hayana madhumuni ya kufanya biashara au uwekezaji, kodi, kisheria, uhasibu au ushauri mwingine. Google si mshauri wa uwekezaji wala mshauri wa kifedha na haitoi maoni au mapendekezo yanayohusiana na kampuni zozote zilizojumuishwa kwenye orodha hii au hisa zozote zilizotolewa na kampuni hizo. Tafadhali wasiliana na dalali wako au mwakilishi wa kifedha ili uthibitishe bei kabla ya kufanya biashara yoyote. Pata maelezo zaidi
Watu pia hutafuta
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu